Digital biomarkers (DBMs) are a growing field and increasingly tested in the therapeutic
areas of psychiatric and neurodegenerative disorders. Meanwhile, isolated silos of
knowledge of audiovisual DBMs use in industry, academia, and clinics hinder their
widespread adoption in clinical research. How can we help these non-technical domain
experts to explore audiovisual digital biomarkers? The use of open source software in
biomedical research to extract patient behavior changes is growing and inspiring a shift …